Hayden-Ledbetter; Martha
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hayden-Ledbetter; Martha.The latest application filed is for "therapeutic nuclease compositions and methods".
Company Profile
4.19.33
- Hayden-Ledbetter; Martha - Seattle WA
- Hayden-Ledbetter; Martha - Shoreline WA
Patent Activity
| Patent | Date |
|---|---|
| Therapeutic nuclease compositions and methods Grant 11,306,297 - Ledbetter , et al. April 19, 2 | 2022-04-19 |
| Therapeutic Nuclease Compositions and Methods App 20210395711 - Ledbetter; Jeffrey A. ; et al. | 2021-12-23 |
| Therapeutic nuclease compositions and methods Grant 11,034,944 - Ledbetter , et al. June 15, 2 | 2021-06-15 |
| Therapeutic Nuclease Compositions and Methods App 20190119660 - Ledbetter; Jeffrey A. ; et al. | 2019-04-25 |
| Therapeutic nuclease compositions and methods Grant 10,202,588 - Ledbetter , et al. Feb | 2019-02-12 |
| Therapeutic Nuclease Compositions and Methods App 20180187174 - Ledbetter; Jeffrey A. ; et al. | 2018-07-05 |
| Therapeutic nuclease compositions and methods Grant 10,000,745 - Ledbetter , et al. June 19, 2 | 2018-06-19 |
| Therapeutic nuclease compositions and methods Grant 9,790,479 - Ledbetter , et al. October 17, 2 | 2017-10-17 |
| Molecules that bind CD180, compositions and methods of use Grant 9,416,188 - Chaplin , et al. August 16, 2 | 2016-08-16 |
| Molecules That Bind Cd180, Compositions And Methods Of Use App 20160168257 - Chaplin; Jay ; et al. | 2016-06-16 |
| Molecules that bind CD180, compositions and methods of use Grant 9,260,529 - Hayden-Ledbetter , et al. February 16, 2 | 2016-02-16 |
| Diagnosis Of Carcinomas App 20160033512 - Hellstrom; Ingegerd ; et al. | 2016-02-04 |
| Diagnosis of carcinomas Grant 9,090,712 - Hellstrom , et al. July 28, 2 | 2015-07-28 |
| Therapeutic Nuclease Compositions and Methods App 20150152399 - Ledbetter; Jeffrey A. ; et al. | 2015-06-04 |
| Therapeutic Nuclease Compositions And Methods App 20150037871 - Ledbetter; Jeffrey A. ; et al. | 2015-02-05 |
| Therapeutic nuclease compositions and methods Grant 8,937,157 - Ledbetter , et al. January 20, 2 | 2015-01-20 |
| Binding domain-immunoglobulin fusion proteins Grant 8,853,366 - Ledbetter , et al. October 7, 2 | 2014-10-07 |
| Therapeutic nuclease compositions and methods Grant 8,841,416 - Ledbetter , et al. September 23, 2 | 2014-09-23 |
| Therapeutic Nuclease Compositions And Methods App 20140227269 - Ledbetter; Jeffrey A. ; et al. | 2014-08-14 |
| Therapeutic Nuclease Compositions and Methods App 20140178379 - Ledbetter; Jeffrey A. ; et al. | 2014-06-26 |
| Therapeutic Nuclease Compositions and Methods App 20140044711 - Ledbetter; Jeffrey A. ; et al. | 2014-02-13 |
| Binding Domain-immunoglobulin Fusion Proteins App 20140010809 - LEDBETTER; Jeffrey A. ; et al. | 2014-01-09 |
| Therapeutic Nuclease Compositions And Methods App 20130183308 - Ledbetter; Jeffrey A. ; et al. | 2013-07-18 |
| Therapeutic Nuclease Compositions And Methods App 20130184334 - Ledbetter; Jeffrey A. ; et al. | 2013-07-18 |
| Therapeutic Nuclease Compositions And Methods App 20130177561 - Ledbetter; Jeffrey A. ; et al. | 2013-07-11 |
| Therapeutic Nuclease Compositions And Methods App 20130089546 - Ledbetter; Jeffrey A. ; et al. | 2013-04-11 |
| Therapeutic Nuclease Compositions And Methods App 20120225066 - Ledbetter; Jeffrey A. ; et al. | 2012-09-06 |
| Binding Domain-immunoglobulin Fusion Proteins App 20120213773 - Ledbetter; Jeffrey A. ; et al. | 2012-08-23 |
| Molecules that bind CD180, compositions and methods of use App 20120020965 - Chaplin; Jay ; et al. | 2012-01-26 |
| Binding constructs and methods for use thereof Grant 7,829,084 - Ledbetter , et al. November 9, 2 | 2010-11-09 |
| Diagnosis Of Carcinomas App 20100047818 - Hellstrom; Ingegerd ; et al. | 2010-02-25 |
| Binding Domain-immunoglobulin Fusion Proteins App 20100034820 - Ledbetter; Jeffrey A. ; et al. | 2010-02-11 |
| Binding Constructs And Methods For Use Thereof App 20090196870 - Ledbetter; Jeffrey A. ; et al. | 2009-08-06 |
| Diagnosis of carcinomas App 20090104684 - Schummer; Michel ; et al. | 2009-04-23 |
| DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40 App 20090074814 - Ledbetter; Jeffrey A. ; et al. | 2009-03-19 |
| Diagnosis of ovarian carcinomas Grant 7,270,960 - Hellstrom , et al. September 18, 2 | 2007-09-18 |
| DNA vaccines encoding antigen linked to a domain that binds CD40 App 20070025982 - Ledbetter; Jeffrey A. ; et al. | 2007-02-01 |
| DNA vaccines encoding antigen linked to a domain that binds CD40 Grant 7,118,751 - Ledbetter , et al. October 10, 2 | 2006-10-10 |
| Compositions and methods for regulating lymphocyte activation App 20050261478 - Ledbetter, Jeffrey A. ; et al. | 2005-11-24 |
| Binding constructs and methods for use thereof App 20050136049 - Ledbetter, Jeffrey A. ; et al. | 2005-06-23 |
| Compositions and methods for regulating lymphocyte activation App 20040253250 - Ledbetter, Jeffrey A. ; et al. | 2004-12-16 |
| Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB App 20040058445 - Ledbetter, Jeffrey Alan ; et al. | 2004-03-25 |
| Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion protein App 20030219436 - Ledbetter, Jeffrey A. ; et al. | 2003-11-27 |
| Diagnosis of carcinomas App 20030108965 - Schummer, Michel ; et al. | 2003-06-12 |
| Compositions And Methods For Regulating Lymphocyte Activation App 20020155604 - LEDBETTER, JEFFREY A. ; et al. | 2002-10-24 |
Company Registrations
| SEC | 0001378510 | HAYDEN-LEDBETTER MARTHA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 